Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,335 | 22 | 42.0% |
| Food and Beverage | $14,357 | 944 | 28.2% |
| Consulting Fee | $11,700 | 6 | 23.0% |
| Travel and Lodging | $3,125 | 29 | 6.1% |
| Education | $312.17 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $19,428 | 110 | $0 (2024) |
| Allergan, Inc. | $9,603 | 98 | $0 (2021) |
| Biogen, Inc. | $8,080 | 101 | $0 (2024) |
| ABBVIE INC. | $3,560 | 149 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $1,291 | 4 | $0 (2021) |
| UCB, Inc. | $948.49 | 57 | $0 (2024) |
| EMD Serono, Inc. | $754.11 | 46 | $0 (2024) |
| Amgen Inc. | $447.85 | 25 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $439.28 | 21 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $342.62 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,607 | 103 | ABBVIE INC. ($432.65) |
| 2023 | $1,759 | 131 | ABBVIE INC. ($394.91) |
| 2022 | $1,561 | 103 | ABBVIE INC. ($401.11) |
| 2021 | $5,371 | 104 | AbbVie Inc. ($2,165) |
| 2020 | $9,289 | 89 | Allergan, Inc. ($7,172) |
| 2019 | $1,662 | 111 | Biogen, Inc. ($229.04) |
| 2018 | $16,151 | 151 | Teva Pharmaceuticals USA, Inc. ($14,696) |
| 2017 | $13,429 | 216 | Biogen, Inc. ($7,071) |
All Payment Transactions
1,008 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology and Neurology | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: AMANTADINE | ||||||
| 12/05/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Neurology | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: RETT SYNDROME | ||||||
| 11/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Neurology | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Analgesic | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neurology | ||||||
| 10/29/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,161 | 1,747 | $345,650 | $127,416 |
| 2022 | 21 | 1,385 | 2,161 | $360,046 | $153,427 |
| 2021 | 16 | 1,188 | 1,747 | $298,820 | $131,715 |
| 2020 | 19 | 1,101 | 1,729 | $238,538 | $114,856 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 499 | 854 | $145,017 | $57,907 | 39.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 133 | 267 | $41,453 | $16,072 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $26,119 | $10,156 | 38.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 48 | $37,570 | $7,566 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 69 | $15,724 | $6,298 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 59 | $13,824 | $6,096 | 44.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 60 | $18,721 | $5,983 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 72 | $14,785 | $4,160 | 28.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $9,513 | $3,312 | 34.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 17 | 32 | $6,543 | $3,218 | 49.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $4,248 | $1,974 | 46.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 25 | 33 | $2,082 | $1,096 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,656 | $705.43 | 42.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 17 | 17 | $2,762 | $685.07 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,900 | $654.83 | 34.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $988.00 | $595.31 | 60.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $1,144 | $496.03 | 43.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 19 | 31 | $1,601 | $440.78 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 491 | 967 | $157,619 | $67,993 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 190 | 190 | $39,859 | $16,865 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 217 | $28,657 | $11,822 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 83 | 101 | $23,059 | $10,737 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 74 | 121 | $27,552 | $8,048 | 29.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $14,506 | $7,037 | 48.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $11,841 | $5,012 | 42.3% |
About Dr. David Ewing, MD
Dr. David Ewing, MD is a Neurology healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639283369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ewing, MD has received a total of $50,829 in payments from pharmaceutical and medical device companies, with $1,607 received in 2024. These payments were reported across 1,008 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,335).
As a Medicare-enrolled provider, Ewing has provided services to 4,835 Medicare beneficiaries, totaling 7,384 services with total Medicare billing of $527,415. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Saint Joseph, MO
- Active Since 08/19/2006
- Last Updated 01/05/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639283369
Products in Payments
- COPAXONE (Drug) $18,767
- UBRELVY (Drug) $11,282
- TYSABRI (Biological) $7,596
- Wakix (Drug) $1,291
- NURTEC ODT (Drug) $608.22
- Briviact (Drug) $572.58
- QULIPTA (Drug) $564.89
- BOTOX (Biological) $417.13
- AUSTEDO (Drug) $357.28
- APTIOM (Drug) $349.88
- Rebif (Biological) $315.10
- Gamunex-C (Biological) $312.87
- NAMZARIC (Drug) $300.92
- Aimovig (Biological) $291.39
- DUOPA (Drug) $285.94
- NUPLAZID (Drug) $284.12
- AUBAGIO (Drug) $283.11
- TECFIDERA (Drug) $261.41
- ZEPOSIA (Drug) $201.26
- ACTHAR (Biological) $194.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Saint Joseph
Abdallah Amireh, Md, MD
Neurology — Payments: $2,376
Chelsea Meyer, D.o, D.O
Neurology — Payments: $1,788
Dr. Robert Ward, D.o, D.O
Neurology — Payments: $1,719
Dr. Peter Spencer, D.o, D.O
Neurology — Payments: $1,615
Dr. Holly Clausen, Phd, Lp, PHD, LP
Neurology